why choose us

First received: February 09, 2023

Clinical Trial: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced or Metastatic Solid Tumors

Study Type: INTERVENTIONAL


Official Title: An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of PRTH-101 Alone or in Combination With Pembrolizumab in Adults Wi

Brief Summary: The goal of this Open-Label Study is to evaluate the safety and tolerability of PRTH-101 alone or in combination with pembrolizumab in adults with advance or metastatic solid tumors.

Read more